FDA approves ZOMIG Nasal Spray migraine treatment for use in the US in paediatric patients
17 June 2015 | By Victoria White
The FDA has approved ZOMIG Nasal Spray for use in the US in paediatric patients 12 years of age and older for the treatment of migraine with or without aura...